These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3123441

  • 1. Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice.
    Kondo H, Tanaka N, Orita K.
    Jpn J Cancer Res; 1987 Dec; 78(12):1400-8. PubMed ID: 3123441
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
    [Abstract] [Full Text] [Related]

  • 3. [Combined effect of human recombinant interferon-beta and interferon-gamma against an experimental model of peritonitis carcinomatosa in nude mice].
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1836-40. PubMed ID: 3109328
    [Abstract] [Full Text] [Related]

  • 4. [Synergistic effect of recombinant human interferon-beta and -gamma on human colon cancer transplanted into nude mice].
    Naomoto Y, Tanaka N, Kondo H, Orita K.
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3155-60. PubMed ID: 3096215
    [Abstract] [Full Text] [Related]

  • 5. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
    Ono M, Tanaka N.
    In Vivo; 1997 Oct; 11(3):233-41. PubMed ID: 9239517
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.
    Morikawa K, Fan D, Denkins YM, Levin B, Gutterman JU, Walker SM, Fidler IJ.
    Cancer Res; 1989 Feb 15; 49(4):799-805. PubMed ID: 2492206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytokines and pancreatic cancer. Sensitivity of xenotransplants of predominantly pancreatic carcinomas to rIFN-gamma and rTFN-alpha in nude mice.
    Kühl JS, Klapdor R, Bahlo M, Franke N, Kunde C, Arps H, Dietel M.
    Int J Pancreatol; 1989 Apr 15; 4(3):303-19. PubMed ID: 2503584
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S.
    Gan To Kagaku Ryoho; 1985 Feb 15; 12(2):284-8. PubMed ID: 3970552
    [Abstract] [Full Text] [Related]

  • 12. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M.
    Anticancer Res; 1993 Feb 15; 13(2):369-73. PubMed ID: 8517649
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y, Sun X, Xu M, Tan X, Sasson A, Rashidi B, Han Q, Tan X, Wang X, An Z, Sun FX, Hoffman RM.
    Clin Cancer Res; 1999 Aug 15; 5(8):2157-63. PubMed ID: 10473100
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O, Baba M, Saito A, Yamashita T, Sato W, Abe H, Fukazawa N, Suzuki T, Sato S, Naito M, Tsuruo T.
    Oncol Res; 1997 Aug 15; 9(2):61-9. PubMed ID: 9167187
    [Abstract] [Full Text] [Related]

  • 15. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].
    Gohji K, Hamami G, Kamidono S.
    Hinyokika Kiyo; 1987 Mar 15; 33(3):329-35. PubMed ID: 3113191
    [Abstract] [Full Text] [Related]

  • 16. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM, Moldofsky PJ, Gatenby RA, O'Dwyer J, O'Brien J, Litwin S, Comis RL.
    Cancer Res; 1988 May 01; 48(9):2568-73. PubMed ID: 3128400
    [Abstract] [Full Text] [Related]

  • 17. Antitumor effect of combined intraperitoneal administration of human recombinant interferon-beta and interferon-gamma against intraabdominal carcinomatosis in nude mice.
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Acta Med Okayama; 1988 Apr 01; 42(2):69-75. PubMed ID: 3133927
    [Abstract] [Full Text] [Related]

  • 18. The antitumor effects of IFN- beta against human renal cell carcinoma in athymic nude mice.
    Shirahama T, Kayajima T, Ohi Y.
    In Vivo; 1989 Apr 01; 3(5):345-9. PubMed ID: 2519876
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
    Balkwill FR, Ward BG, Moodie E, Fiers W.
    Cancer Res; 1987 Sep 15; 47(18):4755-8. PubMed ID: 3113722
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.